lactic acid has been researched along with losartan potassium in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.77) | 18.7374 |
| 1990's | 12 (22.64) | 18.2507 |
| 2000's | 14 (26.42) | 29.6817 |
| 2010's | 24 (45.28) | 24.3611 |
| 2020's | 1 (1.89) | 2.80 |
| Authors | Studies |
|---|---|
| Davenport, A; Davison, AM; Khanna, SK; Will, EJ | 1 |
| Christensen, RD; Goodell, H; Hunter, DD; Rothstein, G | 1 |
| Böcker, A; Böning, D; Braumann, KM; Frei, U; Nonnast-Daniel, B | 1 |
| Hempelmann, G; Ratthey, K; Schwanen, N; von Bormann, B; Weidler, B | 1 |
| Bauer, C; Jelkmann, W; Kurtz, A; Malmström, K; Pfuhl, A | 1 |
| Cavalieri, RL; Clemons, GK; Garcia, JF; Jackson, BT; Piasecki, GJ; Schwartz, R; Susa, JB; Teramo, KA; Widness, JA | 1 |
| Cao, HL; Legarth, J; Lingman, G; Persson, B; Rahman, F; Stangenberg, M; Westgren, M | 1 |
| Coles, GA; Henderson, AH; Lewis, NP; Macdougall, IC; Williams, JD; Willis, N | 1 |
| Bárány, P; Bergström, J; Freyschuss, U; Pettersson, E | 1 |
| Jedicke, H; Lange, H; Meierhenrich, R; Voigt, A | 1 |
| Franke, W; Glatzel, E; Gross, J; Lun, A; Messinger, D; Scigalla, P; Sowade, B; Sowade, O; Warnke, H | 1 |
| Bittner, B; Kissel, T; Koll, H; Morlock, M; Winter, G | 1 |
| Kissel, T; Koll, H; Li, YX; Morlock, M; Winter, G | 1 |
| Roberts, D; Smith, DJ | 1 |
| Hirai, K; Kishi, T; Kohzuki, H; Mori, I; Ogoshi, K; Ohno, Y; Okamoto, S; Sakata, S; Sherchand, JB; Shimamoto, I; Shimizu, S; Takaki, M; Ueda, M; Yanagi, S | 1 |
| Dimitriou, M; Kremenopoulos, G; Mussafiris, C; Savopoulou, P; Soubasi, V; Tsantali, C | 1 |
| Butler, M; Huzel, N; Wang, MD; Yang, M | 1 |
| Ashenden, MJ; Gore, CJ; Hahn, AG; Parisotto, R; Russell, G | 1 |
| Sun, XM; Zhang, YX | 1 |
| Bouix, D; Caillaud, C; Casties, JF; Connes, P; Mercier, J | 1 |
| Bonmarchand, G; Coquerel, A; Girault, C; Le Cam-Duchez, V; Menard, JF; Tamion, F | 1 |
| Ditting, T; Hilgers, KF; Linz, P; Schönweiss, C; Stetter, A; Veelken, R | 1 |
| Boushel, R; Calbet, JA; Juel, C; Lundby, C; Rasmussen, P; Rentsch, RL; Robach, P; Thomsen, JJ | 1 |
| Aylward, E; Burbacher, TM; Juul, SE; Kuratani, J; McPherson, RJ; Richards, T | 1 |
| Boushel, R; Calbet, JA; Koskolou, M; Lundby, C; Rasmussen, P; Robach, P; Thomsen, JJ | 1 |
| Chen, J; Geng, Y; He, M; Jin, T; Wu, F; Yuan, W | 1 |
| Bjarnason, AO; Dagbjartsson, A; Haraldsson, A; Hardardottir, H; Thorkelsson, T; Thorsteinsson, A | 1 |
| Fischer, JP; Hartley, CE; Riccardi, R; Shah, S; Strauss, JA; Varma, M; Yang, ZJ; Zhang, S | 1 |
| Foged, EM; Krogh-Madsen, R; Lundby, C; Nielsen, J; Nielsen, TR; Olsen, NV; Petersen, NC; Rasmussen, P; Secher, NH; Sørensen, TA | 1 |
| Chitrova, S; Dimitrov, A; Emilova, Z; Jarukova, N; Nikolov, A; Pramatarova, T; Radulova, P; Shishkova, R; Sluncheva, B; Vakrilova, L | 1 |
| Kato, M; Kita, J; Kubota, K; Sawada, T; Shimoda, M | 1 |
| Blanco, FJ; Hernández, RM; Herran, E; Igartua, M; Murua, A; Orive, G; Pedraz, JL | 1 |
| Dong, J; Mo, X; Ren, T; Rong, X; Wang, X; Wang, Y; Yang, S; Yuan, W | 1 |
| Feng, M; He, J; Jiang, Y; Ma, S; Wang, Y; Zhang, H; Zhou, X | 1 |
| Figulla, HR; Fritzenwanger, M; Goebel, B; Jung, C; Lauten, A | 1 |
| Biringer, K; Danko, J; Dókus, K; Mat'asová, K; Pullmann, R; Zibolen, M | 1 |
| Du, HJ; Fan, YY; He, JT; Jiang, Y; Wang, Y; Zhang, HX; Zhou, XL | 1 |
| Burris, M; Chen, H; Dou, H; Fajilan, A; Rolland, WB; Spagnoli, F; Tang, J; Zhang, JH | 1 |
| Balaban'ian, VIu; Elizarova, OS; Garibova, TL; Litvinova, SA; Solev, IN; Voronina, TA | 1 |
| Guo, T; Jin, T; Miao, H; Mo, X; Rong, X; Shi, W; Wang, Z; Yang, S; Yuan, W | 1 |
| Balaban'ian, VIu; Barskov, IV; Elizarova, OS; Garibova, TL; Litvinova, SA; Novikova, SV; Stel'mashuk, EV; Voronina, TA | 1 |
| Pietrini, D | 1 |
| Cooke, MJ; Morshead, CM; Sachewsky, N; Shoichet, MS; Wang, Y | 1 |
| Hirano, T; Kakizawa, Y; Koyamatsu, Y; Maeda, M; Okano, F; Takarada, T | 1 |
| Baetiong, A; Borovnik-Lesjak, V; Currie, BM; Gazmuri, RJ; Miao, Y; Radhakrishnan, J; Velmurugan, S; Whitehouse, K | 1 |
| Boushel, R; Calbet, JA; Lundby, C; Nordsborg, NB; Robach, P | 1 |
| Gao, Y; Liu, J; Long, A; Tang, P; Zhang, L; Zhang, W; Zhou, Y | 1 |
| Han, SY; Hong, SK; Jeong, JH; Jeong, YG; Kang, BS; Kang, SH; Kim, DK; Kim, GH; Kim, JH; Lee, IH; Lee, JH; Lee, NS; Lee, SH; Lee, YJ; Yu, KS | 1 |
| Ai, Q; Ao, JE; Duan, R; Ge, P; Gong, X; Lin, L; Zhang, L | 1 |
| Aiba, T; Anzai, T; Asaumi, Y; Higashiyama, A; Honda, S; Honma, T; Iwakami, N; Kanaya, T; Kawakami, S; Kubota, Y; Kusano, K; Nagai, T; Nakai, M; Nishida, Y; Nishimura, K; Noguchi, T; Ogawa, H; Okada, A; Okamura, T; Sugano, Y; Sugiyama, D; Yasuda, S | 1 |
| Gao, Y; Liu, J; Long, A; Tang, P; Zhang, L; Zhang, W; Zhou, G; Zhou, Y | 1 |
| Han, SY; Jeong, JH; Jeong, YG; Kang, SH; Kim, DK; Lee, NS | 1 |
| Hirabayashi, A; Katsuyama, H; Matsuda, K; Nakagawa, H; Nishimura, K; Ohishi, M | 1 |
7 trial(s) available for lactic acid and losartan potassium
| Article | Year |
|---|---|
Evaluation of oxygen availability with oxygen status algorithm in patients undergoing open heart surgery treated with epoetin beta.
Topics: Acidosis; Algorithms; Cardiac Surgical Procedures; Double-Blind Method; Erythropoietin; Female; Humans; Lactic Acid; Male; Middle Aged; Oxygen; Oxygen Consumption; Preoperative Care; Recombinant Proteins | 1997 |
Use of erythropoietin and its effects on blood lactate and 2, 3-diphosphoglycerate in premature neonates.
Topics: 2,3-Diphosphoglycerate; Anemia, Neonatal; Blood Transfusion; Erythropoietin; Fetal Hemoglobin; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Lactic Acid; Prospective Studies; Recombinant Proteins | 2000 |
Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise.
Topics: Administration, Oral; Adult; Analysis of Variance; Carbon Dioxide; Drug Administration Schedule; Erythrocyte Count; Erythropoietin; Exercise; Exercise Test; Female; Heart Rate; Hematocrit; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Iron; Lactic Acid; Male; Oxygen Consumption; Placebos; Recombinant Proteins; Reticulocytes; Treatment Outcome | 2002 |
Injections of recombinant human erythropoietin increases lactate influx into erythrocytes.
Topics: Adult; Anaerobic Threshold; Bicycling; Erythrocytes; Erythropoietin; Exercise Test; Hematocrit; Hemoglobins; Humans; Kinetics; Lactic Acid; Male; Monocarboxylic Acid Transporters; Oxygen Consumption; Physical Endurance; Recombinant Proteins; Reticulocytes; Running; Swimming; Symporters | 2004 |
Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity.
Topics: Absorptiometry, Photon; Adiposity; Adult; Anaerobic Threshold; Athletic Performance; Bicycling; Body Composition; Body Mass Index; Body Weight; Erythropoietin; Exercise Test; Hematocrit; Hemoglobins; Humans; Lactic Acid; Male; Oxygen Consumption; Recombinant Proteins; Single-Blind Method | 2007 |
Effects of erythropoietin administration on cerebral metabolism and exercise capacity in men.
Topics: Adolescent; Adult; Biomarkers; Blood Flow Velocity; Blood Glucose; Blood-Brain Barrier; Brain; Cerebrovascular Circulation; Cognition; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Erythropoietin; Exercise Tolerance; Hematinics; Humans; Hypoxia; Lactic Acid; Male; Middle Cerebral Artery; Muscle, Skeletal; Oxygen; Oxygen Consumption; Perception; Placebo Effect; Pulmonary Ventilation; Recombinant Proteins; Time Factors; Transcranial Magnetic Stimulation; Ultrasonography, Doppler, Transcranial; Young Adult | 2010 |
Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver.
Topics: Aged; Animals; Digestive System Surgical Procedures; Erythropoietin; Female; Hematocrit; Hemoglobins; Humans; L-Lactate Dehydrogenase; Lactic Acid; Length of Stay; Liver Diseases; Male; Middle Aged; Prospective Studies; Reperfusion Injury; Steroids; Tumor Necrosis Factor-alpha | 2010 |
46 other study(ies) available for lactic acid and losartan potassium
| Article | Year |
|---|---|
Blood lactate is reduced following successful treatment of anaemia in haemodialysis patients with recombinant human erythropoietin both at rest and after maximal exertion.
Topics: Adult; Analysis of Variance; Anemia; Combined Modality Therapy; Erythropoietin; Exercise Test; Female; Humans; Kidney Failure, Chronic; Lactates; Lactic Acid; Male; Middle Aged; Physical Exertion; Recombinant Proteins; Renal Dialysis; Rest | 1992 |
Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia.
Topics: Anemia; Bilirubin; Bone Marrow Examination; Bronchopulmonary Dysplasia; Cells, Cultured; Erythroid Precursor Cells; Erythropoietin; Female; Ferritins; Heart Rate; Hematocrit; Humans; Infant; Infant, Newborn; Lactates; Lactic Acid; Male; Recombinant Proteins; Stem Cells; Transferrin; Vitamin E | 1992 |
Improved physical performance after treatment of renal anemia with recombinant human erythropoietin.
Topics: Adult; Anemia; Blood Pressure; Erythropoietin; Female; Heart Rate; Hemoglobins; Humans; Lactates; Lactic Acid; Male; Middle Aged; Physical Exertion; Renal Dialysis | 1991 |
[Perioperative anemia and erythropoiesis].
Topics: Anemia; Blood Transfusion; Blood Volume; Erythrocyte Count; Erythropoiesis; Erythropoietin; Female; Hemoglobinometry; Hip Prosthesis; Humans; Lactates; Lactic Acid; Male; Oxygen; Postoperative Complications; Reticulocytes | 1990 |
Erythropoietin production by fetal mouse liver cells in response to hypoxia and adenylate cyclase stimulation.
Topics: Adenylyl Cyclases; Animals; Cells, Cultured; Cobalt; Colforsin; Cyclic AMP; Enzyme Activation; Erythropoietin; Isoproterenol; Kinetics; Lactates; Lactic Acid; Liver; Mice; Oxygen | 1986 |
Temporal response of immunoreactive erythropoietin to acute hypoxemia in fetal sheep.
Topics: Acidosis; Animals; Erythropoietin; Female; Fetal Blood; Fetal Hypoxia; Hemodynamics; Lactates; Lactic Acid; Methemoglobinemia; Oxygen; Pregnancy; Radioimmunoassay; Sheep; Sodium Nitrite | 1986 |
Erythropoietin concentrations in amniotic fluid and umbilical venous blood from Rh-immunized pregnancies.
Topics: Amniotic Fluid; Carbon Dioxide; Erythropoietin; Female; Gestational Age; Hemoglobins; Humans; Lactates; Lactic Acid; Oxygen; Pregnancy; Pregnancy Complications, Hematologic; Regression Analysis; Rh Isoimmunization; Umbilical Veins | 1993 |
Effects of the correction of renal anaemia by erythropoietin on physiological changes during exercise.
Topics: Adolescent; Adult; Aged; Anemia; Bicarbonates; Erythropoietin; Exercise Tolerance; Female; Humans; Kidney Diseases; Lactates; Lactic Acid; Male; Middle Aged; Oxygen Consumption; Renal Dialysis; Renal Insufficiency | 1993 |
Treatment of anaemia in haemodialysis patients with erythropoietin: long-term effects on exercise capacity.
Topics: Adult; Aged; Anemia; Blood Pressure; Erythropoietin; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Lactates; Lactic Acid; Male; Middle Aged; Oxygen Consumption; Recombinant Proteins; Renal Dialysis; Time Factors | 1993 |
The effect of erythropoietin on lactate, pyruvate and excess lactate under physical exercise in dialysis patients.
Topics: Anaerobic Threshold; Anemia; Case-Control Studies; Energy Metabolism; Erythropoietin; Exercise; Exercise Test; Female; Humans; Kidney Failure, Chronic; Lactates; Lactic Acid; Male; Middle Aged; Pyruvates; Pyruvic Acid; Recombinant Proteins; Renal Dialysis | 1996 |
Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics.
Topics: Calorimetry, Differential Scanning; Dextrans; Drug Compounding; Drug Stability; Erythropoietin; Fluorescein-5-isothiocyanate; Humans; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Recombinant Proteins; Solvents | 1998 |
Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
Topics: Biocompatible Materials; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Stability; Emulsions; Erythropoietin; Excipients; Humans; Lactic Acid; Microspheres; Pharmaceutic Aids; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Recombinant Proteins | 1998 |
Erythropoietin concentration and arterial haemoglobin saturation with supramaximal exercise.
Topics: Adult; Erythropoietin; Exercise; Exercise Test; Humans; Hypoxia; Lactic Acid; Male; Oximetry; Oxygen; Oxyhemoglobins | 1999 |
Correlation between erythropoietin and lactate in humans during altitude exposure.
Topics: Adult; Altitude; Atmospheric Pressure; Erythropoietin; Female; Humans; Lactic Acid; Male; Middle Aged | 2000 |
Erythropoietin production from CHO cells grown by continuous culture in a fluidized-bed bioreactor.
Topics: Amino Acids; Ammonia; Animals; Bioreactors; Cell Division; CHO Cells; Chromatography, Affinity; Cricetinae; Culture Media; Electrophoresis, Capillary; Electrophoresis, Gel, Two-Dimensional; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Glucose; Glutamine; Glycosylation; Lactic Acid | 2002 |
[Effects of glucose on growth, metabolism and EPO expression in recombinant CHO cell cultures].
Topics: Animals; Cell Division; Cells, Cultured; CHO Cells; Cricetinae; Erythropoietin; Glucose; Glutamine; Lactic Acid; Recombinant Proteins; Transgenes | 2001 |
Erythropoietin and renin as biological markers in critically ill patients.
Topics: Aged; Biomarkers; Critical Illness; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Female; Hemoglobins; Humans; Intensive Care Units; Interleukin-6; Lactic Acid; Male; Middle Aged; Renin; Shock, Septic; Survivors | 2004 |
Renal sympathetic nerves modulate erythropoietin plasma levels after transient hemorrhage in rats.
Topics: Animals; Blood Pressure; Erythropoietin; Hemorrhage; Hypotension; Kidney; Kidney Diseases; Lactic Acid; Male; Oxygen; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sympathetic Nervous System; Vascular Resistance | 2007 |
Prenatal cord clamping in newborn Macaca nemestrina: a model of perinatal asphyxia.
Topics: Animals; Animals, Newborn; Asphyxia; Brain; Disease Models, Animal; Electroencephalography; Erythropoietin; Female; Fetal Monitoring; Gliosis; Hypoxia-Ischemia, Brain; Lactic Acid; Macaca nemestrina; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neuroprotective Agents; Placental Circulation; Pregnancy; Seizures; Umbilical Cord | 2007 |
Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?
Topics: Adult; Biological Transport, Active; Blood Glucose; Capillaries; Cardiac Output; Electrocardiography; Erythropoietin; Exercise; Hemodilution; Humans; Lactic Acid; Male; Muscle, Skeletal; Muscle, Smooth, Vascular; Norepinephrine; Oxygen; Oxygen Consumption; Recombinant Proteins; Regional Blood Flow; Rest; Supine Position | 2008 |
Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation.
Topics: Animals; Antibody Formation; Biological Availability; Delayed-Action Preparations; Dextrans; Erythrocyte Count; Erythropoiesis; Erythropoietin; Humans; Lactic Acid; Male; Mice; Mice, Inbred BALB C; Microspheres; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Recombinant Proteins; X-Ray Diffraction | 2008 |
[The effects of normal vaginal delivery on oxygen transport to the fetus].
Topics: Adult; Carbon Dioxide; Case-Control Studies; Cesarean Section; Delivery, Obstetric; Elective Surgical Procedures; Erythroblasts; Erythrocyte Count; Erythropoietin; Female; Fetal Blood; Hemoglobins; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Lactic Acid; Oxygen; Partial Pressure; Pregnancy | 2008 |
Neuroprotective effects of erythropoietin on acute metabolic and pathological changes in experimentally induced neurotrauma.
Topics: Acute Disease; Animals; Brain Injuries; Disease Models, Animal; Energy Metabolism; Erythropoietin; Glucose; Glutamic Acid; Lactic Acid; Microdialysis; Neuroprotective Agents; Pyruvic Acid; Rats; Rats, Sprague-Dawley | 2008 |
[Treatment of anaemia of prematurity with SS-R-Hu-erythropoietin and significance of hypoxia-inducible factor].
Topics: Anemia, Neonatal; Erythrocyte Transfusion; Erythropoietin; Hematocrit; Hemoglobinometry; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Infant, Newborn; Infant, Premature; Lactic Acid; Recombinant Proteins | 2010 |
Design of a composite drug delivery system to prolong functionality of cell-based scaffolds.
Topics: Alginates; Animals; Biocompatible Materials; Capsules; Delayed-Action Preparations; Dexamethasone; Drug Carriers; Drug Delivery Systems; Drug Implants; Erythropoietin; Female; Gels; Glucocorticoids; Hematocrit; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Microspheres; Myoblasts; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polylysine; Time Factors; Tissue Scaffolds | 2011 |
Neuroprotective effect of erythropoietin-loaded composite microspheres on retinal ganglion cells in rats.
Topics: Animals; Delayed-Action Preparations; Dextrans; Drug Carriers; Emulsions; Erythropoietin; Glial Fibrillary Acidic Protein; Humans; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells | 2011 |
Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
Topics: Animals; Drug Compounding; Drug Stability; Emulsions; Erythrocyte Count; Erythropoietin; Excipients; Hemoglobins; Humans; Lactic Acid; Male; Mice; Mice, Inbred BALB C; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Serum Albumin | 2011 |
Impact of short-term systemic hypoxia on phagocytosis, cytokine production, and transcription factor activation in peripheral blood cells.
Topics: Adult; Atmospheric Pressure; CD4-Positive T-Lymphocytes; Cytokines; Erythropoietin; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; Male; Monocytes; Neutrophils; NF-kappa B p50 Subunit; Phagocytosis; Transcription Factor RelA; Vascular Endothelial Growth Factor A; Young Adult; Zymosan | 2011 |
[Biochemical aspects of fetal hypoxia].
Topics: Acid-Base Equilibrium; Adult; Erythropoietin; Female; Fetal Blood; Fetal Hypoxia; Humans; Hydrogen-Ion Concentration; Lactic Acid; Nerve Growth Factors; Pregnancy; S100 Calcium Binding Protein beta Subunit; S100 Proteins | 2011 |
Pharmacokinetic and pharmacodynamic profiles of recombinant human erythropoietin-loaded poly(lactic-co-glycolic acid) microspheres in rats.
Topics: Animals; Emulsions; Erythropoietin; Humans; Lactic Acid; Male; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Random Allocation; Rats; Rats, Sprague-Dawley; Recombinant Proteins | 2012 |
Nanoerythropoietin is 10-times more effective than regular erythropoietin in neuroprotection in a neonatal rat model of hypoxia and ischemia.
Topics: Animals; Animals, Newborn; Behavior, Animal; Brain Ischemia; Cerebral Infarction; Erythropoietin; Excipients; Female; Hypoxia, Brain; Injections, Intraperitoneal; Lactic Acid; Male; Nanoparticles; Nervous System Diseases; Neuroprotective Agents; Organ Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Postural Balance; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Rotarod Performance Test | 2012 |
[Neuroprotector effect of human recombinant erythropoietin sorbed on polymer nanoparticles studied on model of intracerebral post-traumatic hematoma (hemorrhagic stroke)].
Topics: Adsorption; Amnesia; Animals; Cerebral Hemorrhage; Disease Models, Animal; Enbucrilate; Erythropoietin; Humans; Lactic Acid; Male; Motor Activity; Nanoparticles; Neuroprotective Agents; Paralysis; Paresis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Recombinant Proteins; Stroke; Survival Rate; Weight Loss | 2011 |
Effects of erythropoietin-dextran microparticle-based PLGA/PLA microspheres on RGCs.
Topics: Animals; Apoptosis; Biocompatible Materials; Cell Survival; Cells, Cultured; Delayed-Action Preparations; Dextrans; Disease Models, Animal; Drug Carriers; Drug Compounding; Erythropoietin; Glial Fibrillary Acidic Protein; Immunohistochemistry; In Situ Nick-End Labeling; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Retinal Degeneration; Retinal Ganglion Cells | 2012 |
[Neuroprotective effect of recombinant human erythropoietin-loaded poly(lactic-co-glycolic) acid nanoparticles in rats with intracerebral posttraumatic hematoma].
Topics: Amnesia; Animals; Avoidance Learning; Cerebral Hemorrhage, Traumatic; Disease Models, Animal; Drug Carriers; Erythropoietin; Humans; Lactic Acid; Male; Nanoparticles; Neuroprotective Agents; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Recombinant Proteins; Survival Rate | 2012 |
Intraoperative management of blood loss during craniosynostosis surgery.
Topics: Blood Gas Analysis; Blood Loss, Surgical; Blood Substitutes; Blood Transfusion, Autologous; Child; Craniosynostoses; Erythropoietin; Hemodilution; Humans; Intraoperative Care; Lactic Acid; Monitoring, Intraoperative | 2013 |
Bioengineered sequential growth factor delivery stimulates brain tissue regeneration after stroke.
Topics: Absorbable Implants; Animals; Brain; Delayed-Action Preparations; Drug Delivery Systems; Epidermal Growth Factor; Erythropoietin; Humans; Lactic Acid; Male; Methylcellulose; Mice; Mice, Inbred C57BL; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Recombinant Proteins; Regeneration; Stroke | 2013 |
pH-responsive release of proteins from biocompatible and biodegradable reverse polymer micelles.
Topics: Animals; Biocompatible Materials; Cattle; Delayed-Action Preparations; Erythropoietin; HeLa Cells; Humans; Hydrogen-Ion Concentration; Lactic Acid; Micelles; Phospholipids; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Serum Albumin, Bovine | 2014 |
Effects of intraosseous erythropoietin during hemorrhagic shock in swine.
Topics: Animals; Cytokines; Disease Models, Animal; Erythropoietin; Heart; Hemodynamics; Infusions, Intraosseous; Lactic Acid; Male; Myocardium; Oxygen Consumption; Resuscitation; Shock, Hemorrhagic; Swine | 2014 |
Erythropoietin does not reduce plasma lactate, H⁺, and K⁺ during intense exercise.
Topics: Adult; Erythropoietin; Exercise; Exercise Test; Hematinics; Homeostasis; Humans; Hydrogen-Ion Concentration; Lactic Acid; Leg; Male; Muscle, Skeletal; Oxygen Consumption; Physical Exertion; Potassium; Recombinant Proteins; Regional Blood Flow; Young Adult | 2015 |
Localized and sustained delivery of erythropoietin from PLGA microspheres promotes functional recovery and nerve regeneration in peripheral nerve injury.
Topics: Animals; Capsules; Delayed-Action Preparations; Diffusion; Erythropoietin; Lactic Acid; Male; Nerve Regeneration; Neuroprotective Agents; Peripheral Nerve Injuries; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Recovery of Function; Treatment Outcome | 2015 |
Protective effects of poly(lactic-co-glycolic acid) nanoparticles loaded with erythropoietin stabilized by sodium cholate against glutamate-induced neurotoxicity.
Topics: Cell Line, Tumor; Cell Survival; Drug Stability; Erythropoietin; Glutamic Acid; Humans; Lactic Acid; Nanoparticles; Neuroblastoma; Neurons; Neuroprotective Agents; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Recombinant Proteins; Sodium Cholate | 2014 |
Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis.
Topics: Animals; Anti-Inflammatory Agents; Blood Coagulation; Disease Models, Animal; Erythropoietin; Galactosamine; Hepatitis; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Matrix Metalloproteinase 3; Metformin; Mice; NF-kappa B; Plasminogen Activator Inhibitor 1; RNA, Messenger; Thromboplastin; Up-Regulation; Vascular Endothelial Growth Factor A | 2015 |
Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Anemia; Cause of Death; Cohort Studies; Disease Progression; Erythropoietin; Female; Glomerular Filtration Rate; Heart Failure; Hemoglobins; Humans; Lactic Acid; Male; Middle Aged; Mortality; Multivariate Analysis; Oximetry; Plasma Volume; Prognosis; Proportional Hazards Models; Prospective Studies; Registries; Renal Insufficiency | 2016 |
A sequential delivery system employing the synergism of EPO and NGF promotes sciatic nerve repair.
Topics: Animals; Erythropoietin; Humans; Lactic Acid; Male; Microspheres; Nerve Growth Factor; Nerve Regeneration; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2017 |
Protective Effect of Cholic Acid-Coated Poly Lactic-Co-Glycolic Acid (PLGA) Nanoparticles Loaded with Erythropoietin on Experimental Stroke.
Topics: Animals; Cholic Acid; Drug Carriers; Erythropoietin; Glycolates; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Stroke | 2019 |
Effects of sorbitol and lactate on erythropoietin production in HepG2 cells.
Topics: Animals; Dietary Supplements; Dose-Response Relationship, Drug; Erythropoietin; Hep G2 Cells; Humans; Lactic Acid; Male; Oxidation-Reduction; Rats; Rats, Wistar; RNA, Messenger; Sorbitol; Structure-Activity Relationship | 2020 |